AURORA, ON, June 12, 2013 /CNW/ - Prollenium Medical Technologies Inc.
has opened its new facility, just north of Toronto, making it the only
manufacturer of dermal fillers for tissue reconstruction in Canada.
Prollenium is widely recognized as a leading manufacturer of medical
devices used in cosmetic and plastic surgery treatments worldwide.
Prollenium focuses its efforts on the research, marketing and sales of
biomaterials that can be used in a wide array of tissue reconstruction
applications. "This new facility now offers a much more proactive
opportunity for us to meet changes in the marketplace," says Chief
Executive, Ario Khoshbin, "Allowing us to better innovate our products
and introduce new product extension lines to the market." Manufacturing
its products in-house allows Prollenium to maintain principles of
excellence and trust in the manufacture and design of their products.
The new facility is the only automated syringe manufacturing and
packaging line of viscous gels for implantation in Canada. It employs a
fully automated process in a clean room environment with sterilization,
packaging and quality control taking place in-house. The site is ISO
13485 registered as well as Health Canada and CE approved. It also
houses the company's Marketing, Sales and R&D teams. With continued
success and the opening of the new facility, Prollenium has increased
its workforce significantly in just the past few years.
"Here at Prollenium, we invest heavily in the research and development
of highly innovative products to offer an ever-charging market," says
Senior Vice President Khasha Ighanian. "It is a great accomplishment to
have the ability to design and produce those products here in Canada
under our own roof." Prollenium has an extensive product line extending
from dermal fillers to skincare and revitalization. The company also
has a focus on the therapeutic field. The new location yields a
capacity exceeding over 2 million syringes annually.
For more information, please visit www.prollenium.com
Prollenium Medical Technologies Inc. is a Canadian-based company,
founded in 2002, dedicated to the research, design, manufacture and
distribution of implantable polymers in the
pharmaceutical/dermatological industry. The company is committed to
providing innovative products worldwide that are safe and viable.
Flagship product lines include Revanesse®, Phiderma® and RheoVital™.
SOURCE: Prollenium Medical Technologies Inc.
For further information:
Contact: Brittany Edwards